Literature DB >> 20161352

Asymmetric [4+2] cycloadditions employing 1,3-dienes derived from (R)-4-t-butyldimethyl-silyloxy-2-cyclohexen-1-one.

Zhengmao Hua1, Lei Chen, Yan Mei, Zhendong Jin.   

Abstract

1.3-Dienes derived from (R)-4-t-butyldimethylsilyloxy-2-cyclohexen-1-one react with activated dienophiles to form predominately (or sometimes exclusively) syn/endo products. These controlled [4+2] cycloadditions increase the asymmetric complexity from one asymmetric center in the starting material to five asymmetric centers in the products in a single step, and provide a powerful approach for the asymmetric synthesis of compounds containing the bicyclo[2.2.2]octanone carbon skeleton.

Entities:  

Year:  2009        PMID: 20161352      PMCID: PMC2776744          DOI: 10.1016/j.tetlet.2009.09.055

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  13 in total

1.  Inductive and Resonance Effects of Substituents on pi-Face Selection.

Authors:  A S Cieplak
Journal:  Chem Rev       Date:  1999-05-12       Impact factor: 60.622

2.  Synthetic studies toward the construction of the cis-decalin portion of superstolides A and B. Application of a sequential double michael reaction and an anionic oxy-Cope rearrangement.

Authors:  Zhengmao Hua; Wensheng Yu; Mei Su; Zhendong Jin
Journal:  Org Lett       Date:  2005-05-12       Impact factor: 6.005

3.  Total synthesis of (+)-apiosporamide: assignment of relative and absolute configuration.

Authors:  David R Williams; David C Kammler; Andrew F Donnell; William R F Goundry
Journal:  Angew Chem Int Ed Engl       Date:  2005-10-21       Impact factor: 15.336

4.  Total synthesis of kinamycins C, F, and J.

Authors:  K C Nicolaou; Hongming Li; Andrea L Nold; Doron Pappo; Achim Lenzen
Journal:  J Am Chem Soc       Date:  2007-08-04       Impact factor: 15.419

5.  Enantio- and diastereoselective total synthesis of (+)-panepophenanthrin, a ubiquitin-activating enzyme inhibitor, and biological properties of its new derivatives.

Authors:  Masayoshi Matsuzawa; Hideaki Kakeya; Junichiro Yamaguchi; Mitsuru Shoji; Rie Onose; Hiroyuki Osada; Yujiro Hayashi
Journal:  Chem Asian J       Date:  2006-12-18

6.  The telescoped intramolecular michael/olefination (TIMO) approach to alpha-alkylidene-gamma-butyrolactones: synthesis of (+)-paeonilactone B.

Authors:  Michael G Edwards; Martin N Kenworthy; Russell R A Kitson; Mark S Scott; Richard J K Taylor
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

7.  Total syntheses and structural revision of alpha- and beta-diversonolic esters and total syntheses of diversonol and blennolide C.

Authors:  K C Nicolaou; Ang Li
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

8.  Solution- and soluble-polymer supported asymmetric syntheses of six-membered ring prostanoids.

Authors:  J A López-Pelegrín; K D Janda
Journal:  Chemistry       Date:  2000-06-02       Impact factor: 5.236

9.  A convergent synthesis of the tricyclic core of the dictyosphaeric acids.

Authors:  Christopher W Barfoot; Alan R Burns; Michael G Edwards; Martin N Kenworthy; Mahmood Ahmed; Stephen E Shanahan; Richard J K Taylor
Journal:  Org Lett       Date:  2007-12-21       Impact factor: 6.005

10.  Welwistatin support studies: expansion and limitation of aryllead(IV) coupling reactions.

Authors:  Jibo Xia; Lauren E Brown; Joseph P Konopelski
Journal:  J Org Chem       Date:  2007-08-09       Impact factor: 4.354

View more
  2 in total

1.  Controlling the facial selectivity of asymmetric [4+2] cyclo-additions: a concise synthesis of the cis-decalin core structure of superstolides A and B.

Authors:  Lei Chen; Zhengmao Hua; Gangqin Li; Zhendong Jin
Journal:  Org Lett       Date:  2011-06-14       Impact factor: 6.005

2.  Asymmetric synthesis of a highly functionalized bicyclo[3.2.2]nonene derivative.

Authors:  Toshiki Tabuchi; Daisuke Urabe; Masayuki Inoue
Journal:  Beilstein J Org Chem       Date:  2013-04-04       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.